Antihemophilic factor Intravenous, Injection and Coronary artery disease
Result of checking the interaction of drug Antihemophilic factor Intravenous, Injection and disease Coronary artery disease for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com no contraindications or side effects have been found, or the interaction effects are not currently understood. Drug use in presence of concomitant diseases is allowed after additional verification and approval by the attending physician.
Generic Name: antihemophilic factor
Brand Name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)